The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-mesothelin chimeric antigen receptor T cells in patients with epithelial ovarian cancer.
 
Janos Laszlo Tanyi
No Relationships to Disclose
 
Andrew R Haas
Consulting or Advisory Role - csa medical
Travel, Accommodations, Expenses - csa medical
 
Gregory Lawrence Beatty
Stock and Other Ownership Interests - Advaxis; Johnson & Johnson
Honoraria - Incyte; Janssen
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Vaccinex
Research Funding - Incyte; Novartis
Other Relationship - Advaxis
 
Caitlin Jane Stashwick
No Relationships to Disclose
 
Mark H. O'Hara
No Relationships to Disclose
 
Mark Aloysuis Morgan
No Relationships to Disclose
 
David L. Porter
Consulting or Advisory Role - Celldex; GlobeImmune; Immune Design
 
Jan J. Melenhorst
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Novartis
 
Gabriela Plesa
No Relationships to Disclose
 
Simon F. Lacey
Research Funding - Novartis
 
Carl H. June
Stock and Other Ownership Interests - Celldex; Immune Design; Tmunity Therapeutics, Inc.
Honoraria - Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Celldex; Immune Design
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties